oYo-Link® SureLight® PE
Rapid, site-specific labeling of compatible antibodies with up to two PE labels. 30 seconds hands-on time, conjugates ready in just 2 hours.
Our mission is to make antibody labeling as simple and consistent as possible, giving scientists confidence in their bioconjugation reactions.
Label your antibody right out of the tube, no purification required with oYo-Link®. Site-specific labeling takes 30-sec hands on time. Label with Oligos, Biotin, Azide, Enzymes and more.
Rapid, site-specific labeling of compatible antibodies with up to two PE labels. 30 seconds hands-on time, conjugates ready in just 2 hours.
Rapid, site-specific labeling of compatible antibodies with up to two APC labels. 30 seconds hands-on time, conjugates ready in just 2 hours.
Applicable for direct conjugation of HRP to primary antibodies for ELISA, IHC & western blotting.
Create conjugates for proximity assays & qPCR-enabled proteomics using oYo-Link® Oligo Custom.
Product Categories
12AlphaThera was co-founded by Dr. Andrew Tsourkas and Dr. James Hui in 2016. Given the prevalent and critical roles of antibody in biomedical research and the limitations of the existing chemical conjugation methods, Drs. Tsourkas and Hui immediately saw the potential of oYo-Link® in helping countless scientists achieve their research goals.
Much of Dr. Tsourkas's early work revolved around the development of nanoparticles for use in the imaging and/or treatment of various diseases, including cancer, atherosclerosis, and autoimmune diseases. Scaling up these particles was severely limited by the low efficiency attachment of the targeting antibodies onto surfaces such as nanoparticles. The company's team of scientists and business leaders has since grown to engage the commercial space.
Born in the TITAN Lab
Dr. Andrew Tsourkas is a Professor of Bioengineering and Head of the Targeted Imaging, Therapeutics and Nanomedicine (TITAN) lab at the University of Pennsylvania.
Better Bioconjugation
New technologies to improve the efficiency of the bioconjugation reaction and control the orientation of proteins and antibodies on surfaces to maximize antibody activity.
Photoreactive Binding Domains
James Hui spearheaded the idea of using photoreactive antibody-binding domains to site-specifically label the heavy chain of Immunoglobulin G (IgG).
LASIC & oYo-Link®
These efforts produced the LASIC technology and the family of reagents now known as oYo-Link®.
Services We Provide
Choose from our range of oYo-Link labels including oligonucleotides, enzymes and fluorescent dyes & proteins, click chemistry, drugs, biotin and epitope tags. See our most popular services below or contact us to tell us more about your project requirements.
PDFoYo Capture Magnetic Beads Protocol
PDFoYo-Link Azide Click Chemistry Protocol
PDFoYo-Link Tetrazine Click Chemistry Protocol
PDFoYo-Link Thiol Maleimide Coupling Protocol
PDFoYo-Link DBCO Click Chemistry Protocol
PDFoYo-Link Antibody Labeling Technology Overview Flyer
PDFoYo-Link Click-Chemistry & Chemical Conjugations Flyer
PDFoYo-Link Photo Crosslinking Device Flyer
PDFoYo-Link Surface Immobilization Flyer
PDFoYo-Link Antibody-Drug Conjugate Reagents Flyer Recent Posts
4
01
Create conjugates for proximity assays & qPCR-enabled proteomics using oYo-Link® Oligo Custom
Read more
02
Proximity Assays for qPCR-enabled Proteomics: Novel Application of Antibody-Oligo conjugates
Read more
03
How to Maximize the Efficiency of your Click Chemistry Reactions
Read more
04
Antibody-Oligonucleotide Conjugation Chemistries
Read more